BALTIMORE – Fourth-quarter payments showed healthy increases for several respiratory drugs. Brand name drugs Brovana (J7605) rose 88 cents to $8.08 per dose and Perforomist (J7606) rose 40 cents to $8.88 per dose.
WASHINGTON – Members of the House Energy and Commerce Oversight Subcommittee cast serious doubt on CMS’s ability to manage its audit contractors at a hearing June 7. As proof, Chairman Rep.
© 2016 United Publications Inc. ALL RIGHTS RESERVED